Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 1,000 shares at $108.16 ($106K) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Scheduled sale ($106k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.65 | 322 | $34K | 31.9% |
| 2 | $105.44 | 426 | $45K | 42.5% |
| 3 | $106.62 | 108 | $12K | 10.9% |
| 4 | $107.42 | 138 | $15K | 14.0% |
| 5 | $108.16 | 6 | $649 | 0.6% |
| Total | $105.60 avg | 1,000 |
| $106K |
| 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |